You are here: Home / Sites / University of Colorado Health Science Center / Bunn, Paul A.

Bunn, Paul A. (M.D.)

Staff, University of Colorado Health Science Center, 303-724-3155

Contact Information

Email:	mailto:paul.bunn@uchsc.edu
Fax:

To update contact information, please visit the Data Management and Coordinating Center.

Open Protocols

None Available.

Closed Protocols

No closed protocols.

Publications

Publication Name	PubMed ID	Journal
Chromosomal aneusomy in bronchial high-grade lesions is associated with invasive lung cancer.	17989344	Am. J. Respir. Crit. Care Med.
Gefitinib therapy in advanced bronchioloalveolar carcinoma: Southwest Oncology Group Study S0126.	16622257	J. Clin. Oncol.
The bronchioloalveolar carcinoma and peripheral adenocarcinoma spectrum of diseases.	17409882	J Thorac Oncol
Biological markers for non-small cell lung cancer patient selection for epidermal growth factor receptor tyrosine kinase inhibitor therapy.	16778092	Clin. Cancer Res.
Spectral karyotyping detects chromosome damage in bronchial cells of smokers and patients with cancer.	17600274	Am. J. Respir. Crit. Care Med.
Promoter characterization of Semaphorin SEMA3F, a tumor suppressor gene.	16005989	Biochim. Biophys. Acta
Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines.	16424029	Cancer Res.
Analysis of orthologous gene expression between human pulmonary adenocarcinoma and a carcinogen-induced murine model.	16314486	Am. J. Pathol.
Baseline gene expression predicts sensitivity to gefitinib in non-small cell lung cancer cell lines.	16877703	Mol. Cancer Res.
High prevalence of occult endobronchial malignancy in high risk patients with moderate sputum atypia.	16022912	Lung Cancer
Analysis of c-ErbB1/epidermal growth factor receptor and c-ErbB2/HER-2 expression in bronchial dysplasia: evaluation of potential targets for chemoprevention of lung cancer.	16609045	Clin. Cancer Res.
HER3 genomic gain and sensitivity to gefitinib in advanced non-small-cell lung cancer patients.	16288303	Br. J. Cancer
Insulin-like growth factor receptor 1 (IGFR-1) is significantly associated with longer survival in non-small-cell lung cancer patients treated with gefitinib.	16600976	Ann. Oncol.
Multi-target interphase fluorescence in situ hybridization assay increases sensitivity of sputum cytology as a predictor of lung cancer.	15350627	Cancer Detect. Prev.
Bronchioloalveolar carcinoma: a model for investigating the biology of epidermal growth factor receptor inhibition.	15217959	Clin. Cancer Res.
Prognostic significance of occult tumor cells in the apheresis products of patients with advanced breast cancer receiving high-dose chemotherapy and autologous hematopoietic progenitor cell support.	15148495	Biol. Blood Marrow Transplant.
High prevalence of endobronchial malignancy in high-risk patients with moderate dysplasia in sputum.	15136448	Chest
Chemoprevention of lung cancer--from biology to clinical reality.	14760107	Ann. Oncol.
Recent developments in biomarkers for the early detection of lung cancer: perspectives based on publications 2003 to present.	15220746	Curr Opin Pulm Med
Comparative analysis of algorithms for signal quantitation from oligonucleotide microarrays.	14751998	Bioinformatics
Epidermal growth factor receptor messenger RNA expression, gene dosage, and gefitinib sensitivity in non-small cell lung cancer.	16707605	Clin. Cancer Res.
A major lung cancer susceptibility locus maps to chromosome 6q23-25.	15272417	Am. J. Hum. Genet.
EU-USA pathology panel for uniform diagnosis in randomised controlled trials for HRCT screening in lung cancer.	16899486	Eur. Respir. J.
RAGE in lung tumors.	17200506	Am. J. Respir. Crit. Care Med.
Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma.	15886315	J. Clin. Oncol.
Antitumor activity of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib (ZD1839, Iressa) in non-small cell lung cancer cell lines correlates with gene copy number and EGFR mutations but not EGFR protein levels.	17145836	Clin. Cancer Res.
Increased HER2 gene copy number is associated with response to gefitinib therapy in epidermal growth factor receptor-positive non-small-cell lung cancer patients.	16051952	J. Clin. Oncol.
Proteomic patterns of preinvasive bronchial lesions.	16179643	Am. J. Respir. Crit. Care Med.
Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer.	15870435	J. Natl. Cancer Inst.
Increased epidermal growth factor receptor gene copy number detected by fluorescence in situ hybridization associates with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma subtypes: a Southwest Oncology Group Study.	15998906	J. Clin. Oncol.
Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis.	12953099	J. Clin. Oncol.
Premalignant evolution of lung cancer: Gilles F Filley lecture.	15136432	Chest
Sputum cytological atypia as a predictor of incident lung cancer in a cohort of heavy smokers with airflow obstruction.	14578133	Cancer Epidemiol. Biomarkers Prev.
Nuclear accumulation of beta-catenin occurs commonly in the epithelial cells of juvenile polyps.	15557107	Pediatr. Res.
Pulmonary prostacyclin synthase overexpression chemoprevents tobacco smoke lung carcinogenesis in mice.	15313935	Cancer Res.
Molecular classification and molecular genetics of human lung cancers.	14981576	Semin. Oncol.
Overexpression of vascular endothelial growth factor and its receptors in bronchial dypslasia demonstrated by quantitative RT-PCR analysis.	15777969	Lung Cancer
Molecular predictors of outcome with gefitinib in a phase III placebo-controlled study in advanced non-small-cell lung cancer.	17075123	J. Clin. Oncol.
Epidermal growth factor receptor gene copy number and protein level are not associated with outcome of non-small-cell lung cancer patients treated with chemotherapy.	17082511	Ann. Oncol.
Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib.	17317677	Ann. Oncol.
Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort.	16540689	Cancer Res.
Predicting gene promoter methylation in non-small-cell lung cancer by evaluating sputum and serum.	17406356	Br. J. Cancer
EGFR-mutant lung adenocarcinoma in a patient with Li-Fraumeni syndrome.	17540308	Lancet Oncol.

To update protocols, publications, biomarkers, or science data, please contact the Informatics Center.

Addresses

To update addresses, please visit the Data Management and Coordinating Center.